HCA Healthcare, Inc. (NYSE:HCA) Shares Bought by Fidelis Capital Partners LLC

Fidelis Capital Partners LLC increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 19.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,386 shares of the company’s stock after acquiring an additional 383 shares during the period. Fidelis Capital Partners LLC’s holdings in HCA Healthcare were worth $646,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the business. Norges Bank purchased a new position in HCA Healthcare in the 4th quarter valued at $547,104,000. Morgan Stanley increased its stake in shares of HCA Healthcare by 51.5% in the 4th quarter. Morgan Stanley now owns 2,229,190 shares of the company’s stock worth $534,917,000 after acquiring an additional 758,127 shares during the last quarter. MFN Partners Management LP grew its holdings in shares of HCA Healthcare by 102.9% in the first quarter. MFN Partners Management LP now owns 1,261,201 shares of the company’s stock valued at $316,081,000 after purchasing an additional 639,701 shares during the period. Arrowstreet Capital Limited Partnership increased its holdings in shares of HCA Healthcare by 14.1% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,800,847 shares of the company’s stock worth $701,948,000 after buying an additional 347,177 shares during the last quarter. Finally, Kinetic Partners Management LP purchased a new position in HCA Healthcare in the third quarter worth approximately $50,524,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on HCA shares. Wells Fargo & Company increased their target price on shares of HCA Healthcare from $303.00 to $315.00 and gave the stock an “equal weight” rating in a research note on Thursday, March 28th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of HCA Healthcare from $330.00 to $359.00 and gave the stock a “buy” rating in a research note on Friday, April 12th. Oppenheimer reaffirmed an “outperform” rating and set a $315.00 target price on shares of HCA Healthcare in a research note on Wednesday, January 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $335.00 price objective on shares of HCA Healthcare in a research report on Wednesday, April 10th. Finally, Raymond James upped their price target on HCA Healthcare from $300.00 to $330.00 and gave the stock an “outperform” rating in a report on Wednesday, January 31st. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $314.05.

Insider Buying and Selling

In other news, SVP Sammie S. Mosier sold 1,645 shares of HCA Healthcare stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $312.00, for a total transaction of $513,240.00. Following the sale, the senior vice president now directly owns 7,646 shares of the company’s stock, valued at $2,385,552. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In related news, EVP Michael S. Cuffe sold 3,200 shares of the business’s stock in a transaction dated Wednesday, January 31st. The stock was sold at an average price of $306.79, for a total value of $981,728.00. Following the completion of the sale, the executive vice president now directly owns 24,929 shares of the company’s stock, valued at $7,647,967.91. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Sammie S. Mosier sold 1,645 shares of the business’s stock in a transaction that occurred on Monday, February 5th. The shares were sold at an average price of $312.00, for a total value of $513,240.00. Following the completion of the sale, the senior vice president now owns 7,646 shares of the company’s stock, valued at $2,385,552. The disclosure for this sale can be found here. Insiders have sold 14,840 shares of company stock valued at $4,588,869 in the last quarter. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock traded up $6.79 on Friday, reaching $303.79. 362,822 shares of the stock were exchanged, compared to its average volume of 1,071,454. The business has a fifty day moving average price of $320.06 and a two-hundred day moving average price of $280.94. The firm has a market capitalization of $80.35 billion, a PE ratio of 15.65, a PEG ratio of 1.50 and a beta of 1.65. The company has a current ratio of 1.18, a quick ratio of 1.02 and a debt-to-equity ratio of 35.07. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $335.83.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, January 30th. The company reported $5.90 earnings per share for the quarter, beating analysts’ consensus estimates of $5.05 by $0.85. HCA Healthcare had a return on equity of 996.30% and a net margin of 8.07%. The firm had revenue of $17.30 billion for the quarter, compared to analysts’ expectations of $16.51 billion. During the same quarter last year, the firm earned $4.64 earnings per share. The firm’s revenue for the quarter was up 11.7% compared to the same quarter last year. As a group, research analysts anticipate that HCA Healthcare, Inc. will post 20.58 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 29th. Stockholders of record on Friday, March 15th were paid a dividend of $0.66 per share. The ex-dividend date was Thursday, March 14th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.87%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.60. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.91%.

HCA Healthcare declared that its board has initiated a share buyback program on Tuesday, January 30th that allows the company to repurchase $6.00 billion in outstanding shares. This repurchase authorization allows the company to repurchase up to 7.4% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s board believes its stock is undervalued.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.